Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

1.66
Delayed Data
As of Jun 29
 -0.10 / -5.68%
Today’s Change
0.61
Today|||52-Week Range
3.50
+97.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues164.8M19.3M1.3M18.1M
 
 
 
 
 
Depreciation And Amortization1.7M2.5M3.8M6.2M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses129.2M125.8M93.4M50.6M
 
 
 
 
 
Research And Development101.7M91.4M68.5M38.3M
 
 
 
 
 
Total Operating Expenses130.9M128.3M97.2M56.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income33.9M-109.0M-95.9M-38.7M
 
 
 
 
 
Extraordinary Charge0.00-2.6M-8.1M-11.7M
 
 
 
 
Interest Expense On Debt3.8M3.5M3.1M2.4M
 
 
 
 
 
Other Expenses10.0K247.0K-23.0K66.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income30.6M-114.4M-107.0M-52.7M
 
 
 
 
 
Net Income30.6M-114.4M-107.0M-52.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS39.7M43.4M50.9M52.3M
 
 
 
 
 
Shares To Calculate EPS Diluted41.5M43.4M50.9M52.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.74-$2.64-$2.10-$1.01
 
 
 
 
 
EPS Diluted$0.74-$2.64-$2.10-$1.01
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account